Can B Corp. CANB
Set alert
0.02 0.00 0.00%
As of Jan 15, 9:30 AM ET
0.0144 Day range 0.0195
0.49 52-week range 15.75
- Open
- 0.016
- Prev close
- 0.01917
- Mkt cap
- 1.03M
- Vol
- 658.95K
- Avg vol
- 2.57K
- EPS
- -0.379
- P/E
- 0.21
- Div yield
- 0.00%
More statistics
- Low
- 0.0144
- High
- 0.0195
- Forward P/E
- 27.00
- Beta
- 0.42
- Short ratio
- 0.00
- Inst. own
- 1.76%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 7.38
- 200-d avg
- 8.30
- 1y target
- 1.20
Key statistics
- Market cap
- 1.03M
- Enterprise value
- 234.51M
- Trailing P/E
- 0.00
- Forward P/E
- 27.00
- PEG ratio
- 0.00
- Price / sales
- 0.33
- Price / book
- 270.00
- EPS (TTM)
- -0.379
- Beta
- 0.42
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 3.09M
- Revenue growth
- 315.80%
- Free cash flow
- -3.54M
- Total cash
- 190.53K
- Total debt
- 6.44M
- Return on equity
- -218.25%
- Shares outstanding
- 1.90M
- Short % of float
- 0.00%
- 50-day average
- 7.38
- 200-day average
- 8.30
Analyst view
Consensus: buy
Buy
Price target (mean) 1.20
Next earnings
Consensus EPS estimate -0.05.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 19, 2024 | Sep 1, 2024 | 0.00 | -0.05 | — | — |
| Aug 19, 2024 | Jun 1, 2024 | 0.00 | -0.04 | — | — |
| May 20, 2024 | Mar 1, 2024 | 0.00 | -0.13 | — | — |
| Nov 20, 2023 | Sep 1, 2023 | 0.00 | -0.36 | — | — |
| Aug 21, 2023 | Jun 1, 2023 | 0.00 | -0.37 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 26, 2021 | Greenridge Global | init | — | Buy |
About Can B Corp.
Can B Corp. produces and sells cannabidiol (CBD) based products in the United States. It provides CBD products derived from hemp, including oils, creams, moisturizers, isolate, gel caps, spa products, and concentrates through its Website and vending machines, and other medical professionals. The company was formerly known as Canbiola Inc. and changed its name to Can B Corp. in February 2020. Can B Corp. was incorporated in 2005 and is based in Hicksville, New York.
- Sector
- Healthcare
- Industry
- Drug Manufacturers—Specialty & Generic
- Country
- United States
- Website
- canbcorp.com
News
- Can B Corp. Announces Holding Company Reorganization With Nascent Pharma Holdings, Inc. to Become the Publicly-Traded Parent Company
- Can B Corp. Secures Ownership and Control of Two Cannabis Patents Valued at $122 Million and Potentially in Excess of $750 Million
- Can B Corp. Expects Nearly $500,000 Annual Savings With Successful Completion of Move of Pure Health Products From Lacey, WA to Colorado
- Can B Corp. Secures 1.8 Million Pounds of Biomass for Awarded Contract With One Bad Moon Rising
- Can B Corp. Secures Lease for 300,000 Square Foot Facility in McMinnville, Tennessee
- Can B Corp. Strengthens Its Vertical Processing Capabilities With Acquisition of Assets From Music City Botanicals
- Can B Corp. Closes Acquisition of Assets from Music City Botanicals to Strengthen its Vertical Processing Capabilities
- Can B Corp. Reports 96% Revenue Growth for Its Second Quarter 2021
- Can B Corp. Closes Acquisition of Assets from TWS Pharma in CO to Significantly Expand Capabilities in Converting Hemp Biomass to Isolate Used in our CBD and Isomer Product Lines
- Can B Corp Announces First Quarter 2021 Results
Your note
Sign in to keep a note on CANB — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ALFONSI MARCO | Chief Executive Officer | Conversion of Exercise of derivative security | Dec 27, 2018 | 59,231,400 |
| DILLEY CARL E | Director | Purchase | Feb 8, 2018 | 4,085,030 |
| HEGGENHOUGEN ROLV E | Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Nov 29, 2017 | 0 |
| MCKENZIE WEBSTER, LTD. | Beneficial Owner of more than 10% of a Class of Security | Sale | Aug 1, 2019 | 61,402,200 |
| ROLV HEGGENHOUGEN | Director | Sale | Dec 20, 2018 | 68,695,700 |